Table 1.
Patient Demographics.
| Complex (n = 49) | Conventional (n = 66) | Exploration (n = 28) | |||||
|---|---|---|---|---|---|---|---|
| Females, n (%) | 23 | (47) | 36 | (55) | 11 | (39) | 0.377 |
| Age, median (IQR) | 70 | (60–75) | 66 | (60–73) | 66 | (57–75) | 0.326 |
| BMI, median (IQR) | 25.9 | (22.9–29.5) | 24.8 | (22.5–28.7) | 25.7 | (23.9–29.1) | 0.931 |
| CKD, n (%) | 6 | (12) | 4 | (6) | 4 | (14) | 0.365 |
| CHD, n (%) | 3 | (6) | 3 | (5) | 4 | (14) | 0.228 |
| Hypertension, n (%) | 68 | (53) | 25 | (38) | 13 | (46) | 0.264 |
| Neoadj. Chemo, n (%) | 6 | (12) | 4 | (6) | 4 | (14) | 0.365 |
| Charlson Com. Index, median (IQR) | 5 | (4–6) | 5 | (4–6) | 7 | (4–8) | 0.582 |
| UICC, n (%) | |||||||
| Stage I | 5 | (10) | 15 | (23) | 1 | (4) | 0.031 |
| Stage II | 13 | (27) | 27 | (41) | 4 | (14) | 0.028 |
| Stage III | 6 | (12) | 5 | (8) | 0 | (0) | 0.152 |
| Stage IV | 25 | (51) | 19 | (29) | 23 | (82) | <0.001 |